申请人:Takayama Tetsuo
公开号:US20110288293A1
公开(公告)日:2011-11-24
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof has an effect of inhibiting CRTH2 and, therefore, is useful as a preventive or a remedy for allergic diseases such as asthma, atopic dermatitis and allergic rhinitis.
化合物(I)的分子式或其药学上可接受的盐具有抑制CRTH2的效果,因此可用作预防或治疗哮喘、特应性皮炎和过敏性鼻炎等过敏性疾病的药物。